217 related articles for article (PubMed ID: 35426920)
1. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
[TBL] [Abstract][Full Text] [Related]
2. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
[TBL] [Abstract][Full Text] [Related]
3. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
4. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
Ma SJ; Yu H; Khan M; Yu B; Santhosh S; Chatterjee U; Gill J; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
Oral Oncol; 2022 Oct; 133():106054. PubMed ID: 35933937
[TBL] [Abstract][Full Text] [Related]
5. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer.
So YK; Lee G; Oh D; Byeon S; Park W; Chung MK
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):303-309. PubMed ID: 29557259
[TBL] [Abstract][Full Text] [Related]
8. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
[TBL] [Abstract][Full Text] [Related]
9. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
10. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
11. Association of Human Papillomavirus Status With Suicide Risk Among Patients With Head and Neck Cancer.
Chakoma T; Moon PK; Osazuwa-Peters OL; Megwalu UC; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):291-299. PubMed ID: 36795392
[TBL] [Abstract][Full Text] [Related]
12. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair.
King AH; Schmaier AH; Harth KC; Kumins NH; Wong VL; Zidar DA; Kashyap VS; Cho JS
J Vasc Surg; 2020 Jul; 72(1):129-137. PubMed ID: 32037083
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio in head and neck cancer.
Haddad CR; Guo L; Clarke S; Guminski A; Back M; Eade T
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):514-519. PubMed ID: 25908427
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer.
Mady M; Prasai K; Tella SH; Yadav S; Hallemeier CL; Rakshit S; Roberts L; Borad M; Mahipal A
HPB (Oxford); 2020 Oct; 22(10):1490-1495. PubMed ID: 32122786
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
20. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]